Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet
- PMID: 29088323
- PMCID: PMC6248721
- DOI: 10.1093/annonc/mdx648
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet
References
-
- Pezaro CJ, Omlin A, Mastris K. et al. Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from ‘castration resistant’ prostate cancer. Ann Oncol 2017; 28(8):1692–1694. - PubMed
-
- Huggins C, Hodges CV.. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972; 22(4): 232–240. - PubMed
-
- Chen CD, Welsbie DS, Tran C. et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10(1): 33–39. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources